|Articles|May 15, 2014
- Pharmaceutical Technology-05-15-2014
- Volume 2014 eBook
- Issue 2
Potential Benefits Drive Interest in Continuous Manufacturing
Author(s)Cynthia A. Challener
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Advertisement
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Download
.
Articles in this issue
about 12 years ago
Continuous Bioprocessing Challengesabout 12 years ago
Achieving and Maintaining Compliance Using Continuous Monitoring Systemsabout 12 years ago
Optimizing the Sterilization of Liquids in Sealed Containersabout 12 years ago
Using Modular Systems in Biopharmaceutical Manufacturingabout 12 years ago
Determining Protein Oxidation Induced During Fill-Finish Operationsabout 12 years ago
Single-Use Technology in Parenteral Fill/FinishAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why the Orzeyful Approval Matters Beyond One Drug Class
2
What Does Moderna's mRNA Flu Vaccine Approval Signal?
3
The FDA Gives Accelerated Approval to Melanoma Treatment
4
What the OSTP’s New Policy Blueprint Means for Pharma Manufacturing and Development
5